33 results on '"Goodman, Karyn A."'
Search Results
2. Impact of facility volume on outcomes in patients with pancreatic cancer treated with radiotherapy.
3. Quality of life (QOL) for patients with esophageal cancer receiving trimodality therapy with induction chemotherapy, chemoradiation, and surgery: Results from CALGB 80803 (Alliance).
4. Where Are All the Women in Industry Advisory Boards?
5. Anal Cancer: Emerging Standards in a Rare Disease.
6. Trends in Anal Cancer: Leveraging Public Health Efforts to Improve Cancer Care.
7. Value of Neoadjuvant Radiation Therapy in the Management of Pancreatic Adenocarcinoma.
8. Randomized Phase II Study of PET Response-Adapted Combined Modality Therapy for Esophageal Cancer: Mature Results of the CALGB 80803 (Alliance) Trial.
9. Designing Dose-Finding Phase I Clinical Trials: Top 10 Questions That Should Be Discussed With Your Statistician.
10. Treatment of Locally Advanced Esophageal Carcinoma: ASCO Guideline.
11. PROSPECT: A randomized phase III trial of neoadjuvant chemoradiation versus neoadjuvant FOLFOX chemotherapy with selective use of chemoradiation, followed by total mesorectal excision (TME) for treatment of locally advanced rectal cancer (LARC)...
12. Using key stakeholder interviews to inform implementation of a cancer center collaborative intervention to improve clinical trial accruals.
13. Patterns of diversity in cancer clinical trial enrollment at a New York City academic health system, 2018-2022.
14. Targeted intra-arterial gemcitabine vs. continuation of IV gemcitabine plus nab-paclitaxel following induction with sequential IV gemcitabine plus nab-paclitaxel and radiotherapy for unresectable locally advanced pancreatic cancer (TIGeR-PaC): A...
15. Incidence and clinical characteristics of patients with LAPC and mesenteric vein thrombosis and current treatment paradigm.
16. Toxicity and efficacy of stereotactic body radiation therapy vs. intensity-modulated radiation therapy for the treatment of locally advanced pancreatic cancer in a phase 3 trial.
17. Timing Is Everything: What Is the Optimal Duration After Chemoradiation for Surgery for Rectal Cancer?
18. Cancer and Fertility Program Improves Patient Satisfaction With Information Received.
19. Diversity, equity, and inclusion in cancer clinical trial enrollment: Laying the groundwork for a cancer center collaborative intervention through key informant interviews.
20. Refining the Role for Adjuvant Radiotherapy in Gastric Cancer: Risk Stratification Is Key.
21. Role of Radiotherapy and Newer Techniques in the Treatment of GI Cancers.
22. Reply to M. Ratain.
23. Neoadjuvant chemotherapy without routine use of radiation therapy for patients with locally advanced rectal cancer: a pilot trial.
24. Neoadjuvant Chemotherapy Without Routine Use of Radiation Therapy for PatientsWith Locally Advanced Rectal Cancer: A Pilot Trial.
25. Physicians' Beliefs About the Benefits and Risks of Adjuvant Therapies for Stage II and Stage III Colorectal Cancer.
26. Long-Term Results of Organ Preservation in Patients With Rectal Adenocarcinoma Treated With Total Neoadjuvant Therapy: The Randomized Phase II OPRA Trial.
27. Patient Advocates and Researchers as Partners in Cancer Research: A Winning Combination.
28. Organ Preservation in Patients With Rectal Adenocarcinoma Treated With Total Neoadjuvant Therapy.
29. The Multimodal Management of Locally Advanced Rectal Cancer: Making Sense of the New Data.
30. Gastroesophageal Junction Adenocarcinoma: Is There an Optimal Management?
31. Biliary Tract Cancer: Epidemiology, Radiotherapy, and Molecular Profiling.
32. Radiation in rectal cancer: what are the options and if/when can it be avoided?
33. Long-term effects of high-dose chemotherapy and radiation for relapsed and refractory Hodgkin's lymphoma.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.